Evidence map›Paper›PMID 37350866›Full record

ArticleRSC advances2023

Cr(vi) permanently binds to the lipid bilayer in an inverted hexagonal phase throughout the reduction process.

Michal Nowakowski, Anna Wiśniewska-Becker, Joanna Czapla-Masztafiak, Jakub Szlachetko, Andrzej Budziak, Żaneta Polańska, Zuzanna Pietralik-Molińska, Maciej Kozak, Wojciech M Kwiatek

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 62% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Michal NowakowskiInstitute of Nuclear Physics Polish Academy of Sciences PL-31342 Krakow Poland wojciech.kwiatek@ifj.edu.pl.ORCID https://orcid.org/0000-0002-3734-7011
Anna Wiśniewska-BeckerJagiellonian University in Krakow, Faculty of Biochemistry, Biophysics and Biotechnology PL-30387 Krakow Poland.
Joanna Czapla-MasztafiakInstitute of Nuclear Physics Polish Academy of Sciences PL-31342 Krakow Poland wojciech.kwiatek@ifj.edu.pl.ORCID https://orcid.org/0000-0001-7706-0296
Jakub SzlachetkoSolaris National Synchrotron Radiation Centre, Jagiellonian University 30-392 Krakow Poland.
Andrzej BudziakAGH University of Science and Technology, Faculty of Energy and Fuels Krakow Poland.
Żaneta PolańskaAdam Mickiewicz University in Poznan, Faculty of Physics PL-61-614 Poznan Poland.
Zuzanna Pietralik-MolińskaAdam Mickiewicz University in Poznan, Faculty of Physics PL-61-614 Poznan Poland.
Maciej KozakAdam Mickiewicz University in Poznan, Faculty of Physics PL-61-614 Poznan Poland.ORCID https://orcid.org/0000-0003-3312-6518
Wojciech M KwiatekInstitute of Nuclear Physics Polish Academy of Sciences PL-31342 Krakow Poland wojciech.kwiatek@ifj.edu.pl.ORCID https://orcid.org/0000-0002-2197-8572
Adam Mickiewicz University in Poznań · PLInstitute of Nuclear Physics, Polish Academy of Sciences · PLJagiellonian University · PLAGH University of Krakow · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cr(vi) is a harmful, carcinogenic agent with a high permeability rate throughout the lipid membranes. In an intracellular environment and during interactions with cellular membranes, it undergoes an instant reduction to lower oxidation states throughout radical states, recognized as the most dangerous factor for cells. The cellular membrane is the most visible cellular organelle in the interior and exterior of a cell. In this study, liposomes and non-lamellar inverted hexagonal phase lipid structures based on phosphoethanolamine (PE) were used as model cellular bilayers because of their simple composition, preparation procedure, and the many other properties of natural systems. The lipid membranes were subjected to 0.075 mM Cr(vi) for 15 min, after which the Cr content was removed

Identifiers

PMID37350866
PMCPMC10282592
OpenAlexW4381662014

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.